GlaxoSmithKline inked trial software firm Medable to a four-year deal to use its platform for decentralized clinical trials and to recruit more diverse trial patient populations.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,